Using the rat anti-miillerian hormone type II receptor (AMHRII) cDNA as a probe, two overlapping lambda phage clones containing the AMHRII gene were isolated from a human genomic library. Sequence analysis of the exons was performed and the exon/intron boundaries were determined. The coding region was found to consist of 11 exons, divided over 8 kb. The genomic structure resembles that of the related activin type II receptor gene. The AMHRII gene was mapped to human chromosome 12q 12-q 13. The results reported are essential for identification of AMHRII gene alterations in patients with persistent mullerian duct syndrome. e> 199s Academic prom-., me. Anti-miillerian hormone (AMI-1) is a member the TGFB family of growth and differentiation factors (1). AMH plays a critical role during male fetal sex differentiation, by inducing regression o f the mullerian ducts, the anlagen of the female urogenital tract (2-4). During fetal life, AMH is produced only by the testicular Sertoli cells, but postnatally this factor is also found in ovarian granulosa cells (5). Previous studies have shown that members of the TGF[3 family exert their action via a heteromeric signalling complex that includes a type I and a type II receptor (6). Both I r no a receptors are transmembrane serine/threonine kinases. The smaller subfamily, that is characterized by a specific cysteine spacing in the extracellular domain and a GS-rich juxtamembrane motif (7).
(AMHRII) cloned, as new members of the serine/threonine kinase receptor family. AMHRII mRNA is expressed in the mesenchymal cells surrounding the miillerian ducts, during the period of fetal development that the miillerian ducts respond to AMH (8) . Furthermore, COS cells transfected with AMHRII cDNA are able to bind AMH (9) . AMHRII mRNA was also found in fetal gonads, and in Sertoli cells and granulosa cells of adult rats, although the function of AMH in the gonads remains to be established (10, 11) .
Failure of AMH action leads to the Persistent Mullerian Duct Syndrome (PMDS), a rare form of male pseudohermaphroditism characterized by the presence of uterus and fallopian tubes in otherwise normally virilized males (12) . In some cases, this phenotype is caused by a mutation in the AMH gene (13) . However, the presence of bioactive AMH in other PMDS patients (14) indicates resistance of the miillerian ducts to AMH, possibly as a result of alterations in the AMHRII gene. A mutation in the AMHRII gene that may result in alternative splicing has recently been reported (15) .
Herein, we present the genomic structure of the human AMHRII gene and its chromosomal localization.
MATERIALS AND METHODS
Library screening: Approximately 1.7 x 10fi plaques of a phage lambda EMBL3 human CMLO (chronic myeloid leukaemia cell line) genomic DNA library were transferred in duplicate to Hybond-N+ nylon filters (Amersham International pic, Little Chalfont, UK), and screened with the full length 1.9 kb rat AMHRII cDNA as a probe (8). The probe was labelled with [32PJ-dATP (Amersham) by random-priming. Hybridization was done o/n at 42 C in 50% formamide, 5xSCC, 5x Denhardt's, 1% SDS, 50 mM Na^HPO./NaH^PO, (pH6.8) and 100 jjg/ml denatured herring sperm DNA. The filters were washed in 2x SCC and 0,1% SDS at 42 C for 10 minutes prior to autoradiography.
Positive phage lambda clones: Four positive clones were identified on initial screening of the genomic library. These clones were purified to homogeneity by secondary and tertiary screening using the rat AMHRII cDNA probe. Phage DNA of 2 positive clones was isolated, digested with several restriction enzymes and analyzed by gel electrophoresis to orient the genomic DNA with respect to the lambda arms. The DNA was transferred to Hybond-N+ filters (Amersham) and probed with fragments of the rat AMHRII cDNA to determine the positions of the 5' and 3' ends of the gene, the overlap, and the coding regions. Fragments of the coding regions were subcloned into the appropriate sites of the vector pBluescript KS(+) (Stratagene, La Jolla, CA, U.S.A.) for sequence analysis.
DNA sequence analysis: DNA sequencing was performed on plasmid DNA by the dideoxy chain termination method, using M13 and human AMHRII primers. Sequence alignments were performed using the sequence analysis program DNAMAN (Lynnon Biosoft, Vaudrieul, Quebec, Canada) and Clustal V.
In situ hybridization to metaphase chromosomes: Phage DNA was labelled with biotin-14-dATP using the bio-NICK system (Life Technologies, Gaithersburg, MD, U.S.A.). The labelled DNA was precipitated with ethanol in the presence of herring sperm DNA. Precipitated DNA was dissolved and denatured at 80 C for 10 min followed by incubation for 30 min at 37 C, and added to heat-denatured chromosome spreads where hybridization was carried out o/n in a moist chamber at 37 C. After posthybridization washing (50% formamide, 2 x SSC, at 42 C) and blocking with nonfat dry milk powder, the hybridized probe was detected using avidin-FITC (Vector Laboratories, Burlingame, CA, U.S.A.) with two amplification steps using rabbit-anti-FITC (Dako, Glostrup, Denmark) and mouse-antirabbit FITC (Jackson Immunoresearch, West Grove, U.S.A.). Chromosome spreads were mounted in antifade solution with blue dye DAPI. 15F(50-58) ) is syntenic with the human chromosome 12, and contains mouse homologues of the genes mentioned above (22) .
RESULTS AND DISCUSSION

Isolation and characterization of the human AMHRII gene
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Chromosomal localization of the AMHRII gene
In conclusion, we have cloned and sequenced the human gene encoding the AMHRII.
The AMHRII is well conserved between mammalian species. This information is essential to identify possible gene alterations in diseases involving the miillerian ducts.
